re: Ann: PHARMAXIS ANNOUNCES SUSTAINED BENEFI... announcement is significant
So what is next - 1) the release of a decision from the US FDA on approval of Aridol in late December 2009 and 2) release of results from the Phase Ia clinical trial for PXS25 for pulmonary fibrosis late in 4QCY09.
- Forums
- ASX - By Stock
- SNT
- Ann: PHARMAXIS ANNOUNCES SUSTAINED BENEFIT WITH B
Ann: PHARMAXIS ANNOUNCES SUSTAINED BENEFIT WITH B, page-3
-
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SNT (ASX) to my watchlist
|
|||||
Last
3.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.82M |
Open | High | Low | Value | Volume |
3.0¢ | 3.3¢ | 3.0¢ | $196.5K | 6.494M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 224999 | 3.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.2¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 224999 | 0.030 |
2 | 80000 | 0.029 |
4 | 1130000 | 0.028 |
4 | 1230000 | 0.027 |
4 | 618461 | 0.026 |
Price($) | Vol. | No. |
---|---|---|
0.032 | 50000 | 1 |
0.033 | 502015 | 4 |
0.034 | 421181 | 4 |
0.035 | 1000000 | 1 |
0.036 | 132000 | 2 |
Last trade - 16.10pm 10/07/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online